Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Times Interest Earned (2020 - 2025)

Rani Therapeutics Holdings has reported Times Interest Earned over the past 6 years, most recently at -$24.6 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$24.6 for Q4 2025, down 84.83% from a year ago — trailing twelve months through Dec 2025 was -$13.25 (down 25.0% YoY), and the annual figure for FY2025 was -$13.25, down 25.1%.
  • Times Interest Earned for Q4 2025 was -$24.6 at Rani Therapeutics Holdings, down from -$10.01 in the prior quarter.
  • Over the last five years, Times Interest Earned for RANI hit a ceiling of $13362.0 in Q4 2021 and a floor of -$252.55 in Q3 2021.
  • Median Times Interest Earned over the past 5 years was -$13.44 (2023), compared with a mean of $712.54.
  • Peak annual rise in Times Interest Earned hit 15775.49% in 2021, while the deepest fall reached 471.75% in 2021.
  • Rani Therapeutics Holdings' Times Interest Earned stood at $13362.0 in 2021, then crashed by 100.18% to -$24.31 in 2022, then surged by 57.37% to -$10.37 in 2023, then dropped by 28.38% to -$13.31 in 2024, then tumbled by 84.83% to -$24.6 in 2025.
  • The last three reported values for Times Interest Earned were -$24.6 (Q4 2025), -$10.01 (Q3 2025), and -$11.98 (Q2 2025) per Business Quant data.